[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20001847D0 - Ny anvendelse av forbindelser for anti-kløe-aktivitet - Google Patents

Ny anvendelse av forbindelser for anti-kløe-aktivitet

Info

Publication number
NO20001847D0
NO20001847D0 NO20001847A NO20001847A NO20001847D0 NO 20001847 D0 NO20001847 D0 NO 20001847D0 NO 20001847 A NO20001847 A NO 20001847A NO 20001847 A NO20001847 A NO 20001847A NO 20001847 D0 NO20001847 D0 NO 20001847D0
Authority
NO
Norway
Prior art keywords
compounds
new use
itch activity
itch
activity
Prior art date
Application number
NO20001847A
Other languages
English (en)
Other versions
NO20001847L (no
Inventor
Don Edgar Griswold
Iv Siegfried Benja Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20001847L publication Critical patent/NO20001847L/no
Publication of NO20001847D0 publication Critical patent/NO20001847D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001847A 1997-10-17 2000-04-10 Ny anvendelse av forbindelser for anti-kløe-aktivitet NO20001847D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number Publication Date
NO20001847L NO20001847L (no) 2000-04-10
NO20001847D0 true NO20001847D0 (no) 2000-04-10

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001847A NO20001847D0 (no) 1997-10-17 2000-04-10 Ny anvendelse av forbindelser for anti-kløe-aktivitet

Country Status (18)

Country Link
EP (1) EP1030666A4 (no)
JP (1) JP2001520196A (no)
KR (1) KR20010031149A (no)
CN (1) CN1306426A (no)
AR (1) AR015966A1 (no)
AU (1) AU740875B2 (no)
BR (1) BR9814080A (no)
CA (1) CA2306985A1 (no)
CO (1) CO4810374A1 (no)
CZ (1) CZ20001376A3 (no)
HU (1) HUP0003792A3 (no)
IL (1) IL135581A0 (no)
NO (1) NO20001847D0 (no)
NZ (1) NZ503551A (no)
PL (1) PL341062A1 (no)
TR (1) TR200001040T2 (no)
WO (1) WO1999020280A1 (no)
ZA (1) ZA989450B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520386A (ja) 2001-01-31 2004-07-08 ファイザー・プロダクツ・インク Ｐｄｅ４アイソザイムの阻害剤として有用なニコチンアミドビアリール誘導体
NZ526531A (en) 2001-01-31 2005-02-25 Pfizer Prod Inc Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
CN1489588A (zh) 2001-01-31 2004-04-14 �Ʒ� 用作pde4同功酶抑制剂的噻唑基,噁唑基,吡咯基,和咪唑基羧酸酰胺衍生物
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
EP1647274A4 (en) * 2003-07-17 2008-12-10 Ono Pharmaceutical Co REMEDY AGAINST PRURIT COMPRISING A PIPERIDINE DERIVATIVE AS AN ACTIVE INGREDIENT
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
WO2005077950A2 (en) * 2004-02-14 2005-08-25 Smithkline Beecham Corporation Medicaments with hm74a receptor activity
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
CA2618963A1 (en) 2005-08-10 2007-02-15 Smithkline Beecham Corporation Xanthine derivatives as selective hm74a agonists
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
AU2007218725B2 (en) * 2006-02-21 2011-12-01 Eisai R & D Management Co., Ltd. 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
EP2123641A4 (en) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd CRYSTAL, AMORPHOUS FORM AND METHYL N-Ý3- (6,7-DIMETHOXY-2-METHYLAMINOQUINAZOLINE-4-YL) PHENYLENE TEREPHTALIC ACID SALT
CN102532041A (zh) 2007-08-17 2012-07-04 卫材R&D管理有限公司 喹唑啉衍生物的制造方法
ATE549320T1 (de) 2007-08-17 2012-03-15 Eisai R&D Man Co Ltd Neue zubereitung für die äusserliche anwendung
WO2013002196A1 (ja) * 2011-06-28 2013-01-03 田辺三菱製薬株式会社 新規医薬組成物
PT3251675T (pt) 2015-01-30 2021-05-25 Shanton Pharma Pte Ltd Prevenção ou tratamento de doença de ácido úrico ou gota

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06504534A (ja) * 1990-12-21 1994-05-26 ビーチャム・グループ・パブリック・リミテッド・カンパニー キサンチン誘導体
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
ATE228131T1 (de) * 1996-05-15 2002-12-15 Altana Pharma Ag Imidazopyridine
PT968211E (pt) * 1997-03-07 2004-01-30 Altana Pharma Ag Derivados de tetrazoles
SK122199A3 (en) * 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
JP2002502403A (ja) * 1997-06-03 2002-01-22 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング ベンゾナフチリジン

Also Published As

Publication number Publication date
WO1999020280A1 (en) 1999-04-29
NO20001847L (no) 2000-04-10
CN1306426A (zh) 2001-08-01
AU1093899A (en) 1999-05-10
NZ503551A (en) 2002-05-31
HUP0003792A2 (hu) 2001-10-28
KR20010031149A (ko) 2001-04-16
JP2001520196A (ja) 2001-10-30
HUP0003792A3 (en) 2001-12-28
TR200001040T2 (tr) 2001-01-22
BR9814080A (pt) 2000-09-26
CA2306985A1 (en) 1999-04-29
AU740875B2 (en) 2001-11-15
CZ20001376A3 (cs) 2002-06-12
PL341062A1 (en) 2001-03-26
IL135581A0 (en) 2001-05-20
AR015966A1 (es) 2001-05-30
ZA989450B (en) 1999-04-19
CO4810374A1 (es) 1999-06-30
EP1030666A1 (en) 2000-08-30
EP1030666A4 (en) 2002-10-16

Similar Documents

Publication Publication Date Title
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
EE200000044A (et) Uued ühendid
ID24372A (id) SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
PT996622E (pt) Novos compostos heterociclicos espiroazabiciclicos
FI972292A (fi) Diabeteksen hallinta
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
NO20015855L (no) Ny anvendelse av forbindelser som antibakterielle midler
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
NO993298D0 (no) Ny fremgangsmÕte
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID24677A (id) Kombinasi senyawa aktif fungisidal
NO995796D0 (no) Ny fremgangsmåte
ID24270A (id) Penghilang sumbatan keratotik
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
FI963532A (fi) Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
ID23437A (id) Penghilang sumbatan keratotik
FI963531A (fi) Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
ID24694A (id) Pemakaian bentuk zat-zat sebagai katalis untuk pembuatan kaprolaktam
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID19787A (id) Senyawa 25-hidroksi-16-ena-26,27-bishomo-kolekalsiferol
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
NO963764D0 (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
NO963762D0 (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
SE9702696D0 (sv) New compounds
SE9702746D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application